5G Chipset Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of 5G Chipset Market
The 5G chipset market size was valued at USD 19.69 billion in 2023, and the market is now projected to grow from USD 25.30 billion in 2024 to USD 218.04 billion by 2030, exhibiting a CAGR of 36.0% during the forecast period of 2024-2030.
The digital and semiconductor industry has been considerably impacted by way of COVID-19, experiencing disruptions from international lockdowns. However, the developing IT and telecommunication sectors and changing consumer behaviors have pushed call for subsequent-gen chipset products. The shift to faraway work and the deliver-your-very own-device fashion has considerably expanded the demand for 5G-enabled chipsets inside the market.
The growing demand for high-speed, low-latency 5G networks is driving marketplace boom, as those networks beautify the performance of smartphones and related gadgets. A 2022 survey indicated that U.S. Customers of 5G clever devices spend drastically more time on their gadgets in comparison to 4G customers, with 5G phone adoption growing from 41% to 63% from 2021 to 2022. This surge, at the side of the proliferation of IoT and related devices, is boosting the call for 5G chipsets in patron electronics, driving worldwide market growth.
The shift in the direction of digitization across numerous industries is using the demand for advanced technology like IoT, business automation, and AI, which require excessive-speed, low-latency 5G-enabled chipsets. These chipsets are vital for actual-time communique in hybrid electric powered and linked cars, enhancing safety and decreasing injuries. Additionally, they enhance intercommunication in manufacturing, helping seamless operations. Consequently, the vast use of 5G chipsets in more than one sectors is fueling worldwide market increase.
Comprehensive Analysis of 5G Chipset Market
The 5G chipset market growth is rising at an exponential rate due to its market segmentation. This marketplace enlargement successfully affords an in-depth local exam thinking about the dominant deliver and demand forces that effect the enterprise. These segmentations are methodically segregated by type analysis, by frequency analysis, by deployment type analysis, by industry vertical analysis. By type analysis include, application Specific Integrated Circuits (ASIC), Radio Frequency Integrated Circuit (RFIC), Millimeter Wave Integrated Circuit (mm Wave IC), Cellular Integrated Circuit (Cellular IC), and others. By frequency analysis include, Sub-6 GHZ, 26-39 GHZ, and above 39 GHz. By deployment type analysis include, smartphones/tablets, connected vehicles, connected devices, broadband access gateway devices, and others. By industry vertical analysis include, energy and utilities, manufacturing, IT and Telecommunication, media and entertainment, transportation and logistics, consumer electronics, healthcare, and others.
The Asia Pacific region lead the 5G chipset market share by benefitting a market size of USD 7.61 billion in 2022 because of the adequate availability of advanced processors and chipsets production gadgets and modern-day research & improvement facilities in developing nations.
The pinnacle players inside the market play a critical function in the enterprise assuring market growth and placing marketplace requirements. These players include, Qualcomm Technologies, Inc. (U.S.), Broadcom (U.S.), Unisoc Communications, Inc. (China), Mediatek Inc. (Taiwan), Intel Corporation (U.S.), Samsung Electronics Co., Ltd. (South Korea), Huawei Technologies Co., Ltd. (China), Qorvo (U.S.), Xilinx Inc. (U.S.), Infineon Technologies AG (Germany) these market players provide a level-playing competitive landscape.
In June 2021, Samsung Electronics launched 3GPP Rel.16 compliant chipsets compatible with next-gen 5G mmWave RFIC and 5G modem SoC, ensuring efficient high-speed, low-latency network performance.
Segmentation Table
Attribute Details
Study Period 2019-2030
Base Year 2022
Estimated Year 2023
Forecast Period 2023-2030
Historical Period 2019-2021
Growth Rate CAGR of 36.0% from 2023 to 2030
Unit Value (USD Billion)
Segmentation By Type
Application Specific Integrated Circuit (ASIC)
Radio Frequency Integrated Circuit (RFIC)
Millimeter Wave Integrated Circuit (mmWave IC)
Cellular Integrated Circuit (Cellular IC)
Others
By Frequency
Sub-6 GHZ
26-39 GHZ
Above 39 GHz
By Deployment Type
Smartphone/Tablets
Connected Vehicles
Connected Devices
Broadband Access Gateway Devices
Others
By Industry Vertical
Energy and Utilities
Manufacturing
IT and Telecommunication
Media and Entertainment
Transportation and Logistics
Consumer Electronics
Healthcare
Others
By Region
North America (By Type, By Frequency, By Deployment Type, By Industry Vertical, and By Country)
- U.S. (By Industry Vertical)
- Canada (By Industry Vertical)
- Mexico (By Industry Vertical)
Europe (By Type, By Frequency, By Deployment Type, By Industry Vertical, and By Country)
- U.K. (By Industry Vertical)
- Germany (By Industry Vertical)
- France (By Industry Vertical)
- Italy (By Industry Vertical)
- Russia (By Industry Vertical)
- Rest of Europe (By Industry Vertical)
Asia Pacific (By Type, By Frequency, By Deployment Type, By Industry Vertical, and By Country)
- China (By Industry Vertical)
- India (By Industry Vertical)
- Japan (By Industry Vertical)
- Southeast Asia (By Industry Vertical)
- Rest of Asia Pacific (By Industry Vertical)
Middle East & Africa (By Type, By Frequency, By Deployment Type, By Industry Vertical, and By Country)
- GCC (By Industry Vertical)
- South Africa (By Industry Vertical)
- Rest of Middle East and Africa (By Industry Vertical)
South America (By Type, By Frequency, By Deployment Type, By Industry Vertical, and By Country)
- Brazil (By Industry Vertical)
- Argentina (By Industry Vertical)
- Rest of South America (By Industry Vertical)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Prevalence of Cardiovascular Diseases, By Key Countries/ Region, 2022/2023
- 4.2. Incidence of Atrial Fibrillation, By Key Countries/ Region, 2022/2023
- 4.3. Epidemiology: Stroke, By Key Countries/ Region, 2022/2023
- 4.4. Number of Percutaneous Coronary Interventions Procedures, By Key Countries, 2022/2023
- 4.5. New Product Launches, By Key Players
- 4.6. Key Industry Developments - Mergers, Acquisition, and Partnerships
- 4.7. Impact of COVID-19 on the Market
- 5. Global Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast – By Product
- 5.1.1. Coronary Stents
- 5.1.1.1. Bare-metal Stent (BMS)
- 5.1.1.2. Drug-eluting Stent (DES)
- 5.1.1.3. Others
- 5.1.2. Structural Heart Devices
- 5.1.2.1. Heart Valves
- 5.1.2.2. Occluders & Others
- 5.1.3. Angioplasty Balloons
- 5.1.4. Catheters
- 5.1.4.1. Diagnostic Catheters
- 5.1.4.1.1. Angiography
- 5.1.4.1.2. IVUS
- 5.1.4.1.3. Others
- 5.1.4.2. Treatment Catheters
- 5.1.4.2.1. Atherectomy
- 5.1.4.2.2. Thrombectomy
- 5.1.4.2.3. Ablation
- 5.1.4.2.4. Others
- 5.1.5. Embolic Protection Devices
- 5.1.6. Others
- 5.2. Market Analysis, Insights and Forecast – By End User
- 5.2.1. Hospitals & ASCs
- 5.2.2. Catheterization Labs & Others
- 5.3. Market Analysis, Insights and Forecast – By Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Latin America
- 5.3.5. Middle East and Africa
- 6. North America Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Product
- 6.1.1. Coronary Stents
- 6.1.1.1. Bare-metal Stent (BMS)
- 6.1.1.2. Drug-eluting Stent (DES)
- 6.1.1.3. Others
- 6.1.2. Structural Heart Devices
- 6.1.2.1. Heart Valves
- 6.1.2.2. Occluders & Others
- 6.1.3. Angioplasty Balloons
- 6.1.4. Catheters
- 6.1.4.1. Diagnostic Catheters
- 6.1.4.1.1. Angiography
- 6.1.4.1.2. IVUS
- 6.1.4.1.3. Others
- 6.1.4.2. Treatment Catheters
- 6.1.4.2.1. Atherectomy
- 6.1.4.2.2. Thrombectomy
- 6.1.4.2.3. Ablation
- 6.1.4.2.4. Others
- 6.1.5. Embolic Protection Devices
- 6.1.6. Others
- 6.2. Market Analysis, Insights and Forecast – By End User
- 6.2.1. Hospitals & ASCs
- 6.2.2. Catheterization Labs & Others
- 6.3. Market Analysis, Insights and Forecast – By Country
- 6.3.1. U.S.
- 6.3.2. Canada
- 7. Europe Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast – By Product
- 7.1.1. Coronary Stents
- 7.1.1.1. Bare-metal Stent (BMS)
- 7.1.1.2. Drug-eluting Stent (DES)
- 7.1.1.3. Others
- 7.1.2. Structural Heart Devices
- 7.1.2.1. Heart Valves
- 7.1.2.2. Occluders & Others
- 7.1.3. Angioplasty Balloons
- 7.1.4. Catheters
- 7.1.4.1. Diagnostic Catheters
- 7.1.4.1.1. Angiography
- 7.1.4.1.2. IVUS
- 7.1.4.1.3. Others
- 7.1.4.2. Treatment Catheters
- 7.1.4.2.1. Atherectomy
- 7.1.4.2.2. Thrombectomy
- 7.1.4.2.3. Ablation
- 7.1.4.2.4. Others
- 7.1.5. Embolic Protection Devices
- 7.1.6. Others
- 7.2. Market Analysis, Insights and Forecast – By End User
- 7.2.1. Hospitals & ASCs
- 7.2.2. Catheterization Labs & Others
- 7.3. Market Analysis, Insights and Forecast – By Country/Sub-region
- 7.3.1. Germany
- 7.3.2. Spain
- 7.3.3. France
- 7.3.4. Italy
- 7.3.5. U.K.
- 7.3.6. Rest of Europe
- 8. Asia Pacific Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast – By Product
- 8.1.1. Coronary Stents
- 8.1.1.1. Bare-metal Stent (BMS)
- 8.1.1.2. Drug-eluting Stent (DES)
- 8.1.1.3. Others
- 8.1.2. Structural Heart Devices
- 8.1.2.1. Heart Valves
- 8.1.2.2. Occluders & Others
- 8.1.3. Angioplasty Balloons
- 8.1.4. Catheters
- 8.1.4.1. Diagnostic Catheters
- 8.1.4.1.1. Angiography
- 8.1.4.1.2. IVUS
- 8.1.4.1.3. Others
- 8.1.4.2. Treatment Catheters
- 8.1.4.2.1. Atherectomy
- 8.1.4.2.2. Thrombectomy
- 8.1.4.2.3. Ablation
- 8.1.4.2.4. Others
- 8.1.5. Embolic Protection Devices
- 8.1.6. Others
- 8.2. Market Analysis, Insights and Forecast – By End User
- 8.2.1. Hospitals & ASCs
- 8.2.2. Catheterization Labs & Others
- 8.3. Market Analysis, Insights and Forecast – By Country/Sub-region
- 8.3.1. China
- 8.3.2. India
- 8.3.3. Japan
- 8.3.4. Australia
- 8.3.5. Southeast Asia
- 8.3.6. Rest of Asia Pacific
- 9. Latin America Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast – By Product
- 9.1.1. Coronary Stents
- 9.1.1.1. Bare-metal Stent (BMS)
- 9.1.1.2. Drug-eluting Stent (DES)
- 9.1.1.3. Others
- 9.1.2. Structural Heart Devices
- 9.1.2.1. Heart Valves
- 9.1.2.2. Occluders & Others
- 9.1.3. Angioplasty Balloons
- 9.1.4. Catheters
- 9.1.4.1. Diagnostic Catheters
- 9.1.4.1.1. Angiography
- 9.1.4.1.2. IVUS
- 9.1.4.1.3. Others
- 9.1.4.2. Treatment Catheters
- 9.1.4.2.1. Atherectomy
- 9.1.4.2.2. Thrombectomy
- 9.1.4.2.3. Ablation
- 9.1.4.2.4. Others
- 9.1.5. Embolic Protection Devices
- 9.1.6. Others
- 9.2. Market Analysis, Insights and Forecast – By End User
- 9.2.1. Hospitals & ASCs
- 9.2.2. Catheterization Labs & Others
- 9.3. Market Analysis, Insights and Forecast – By Country/Sub-region
- 9.3.1. Mexico
- 9.3.2. Brazil
- 9.3.3. Rest of Latin America
- 10. Middle East & Africa Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast – By Product
- 10.1.1. Coronary Stents
- 10.1.1.1. Bare-metal Stent (BMS)
- 10.1.1.2. Drug-eluting Stent (DES)
- 10.1.1.3. Others
- 10.1.2. Structural Heart Devices
- 10.1.2.1. Heart Valves
- 10.1.2.2. Occluders & Others
- 10.1.3. Angioplasty Balloons
- 10.1.4. Catheters
- 10.1.4.1. Diagnostic Catheters
- 10.1.4.1.1. Angiography
- 10.1.4.1.2. IVUS
- 10.1.4.1.3. Others
- 10.1.4.2. Treatment Catheters
- 10.1.4.2.1. Atherectomy
- 10.1.4.2.2. Thrombectomy
- 10.1.4.2.3. Ablation
- 10.1.4.2.4. Others
- 10.1.5. Embolic Protection Devices
- 10.1.6. Others
- 10.2. Market Analysis, Insights and Forecast – By End User
- 10.2.1. Hospitals & ASCs
- 10.2.2. Catheterization Labs & Others
- 10.3. Market Analysis, Insights and Forecast – By Country/Sub-region
- 10.3.1. GCC
- 10.3.2. South Africa
- 10.3.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2023)
- 11.2. Company Profiles
- 11.2.1. Boston Scientific Corporation
- 11.2.1.1. Overview
- 11.2.1.2. Products & Services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Abbott
- 11.2.2.1. Overview
- 11.2.2.2. Products & Services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Medtronic
- 11.2.3.1. Overview
- 11.2.3.2. Products & Services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. BIOTRONIK SE & Co. KG
- 11.2.4.1. Overview
- 11.2.4.2. Products & Services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. iVascular
- 11.2.5.1. Overview
- 11.2.5.2. Products & Services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Terumo Corporation
- 11.2.6.1. Overview
- 11.2.6.2. Products & Services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Teleflex Incorporated
- 11.2.7.1. Overview
- 11.2.7.2. Products & Services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. B. Braun SE
- 11.2.8.1. Overview
- 11.2.8.2. Products & Services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. Alvimedica
- 11.2.9.1. Overview
- 11.2.9.2. Products & Services
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. Biosensors International Group, Ltd
- 11.2.10.1. Overview
- 11.2.10.2. Products & Services
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook